Bexxar blocked: a setback for Corixa

Author：

ISSN： 1537-1328

Source： Pharmaceutical Innovation, Vol.11, Iss.3, 2002-04, pp. : 42-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New setback for angiogenesis inhibitors

Inpharma, Vol. 1, Iss. 1369, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Iodine-131 tositumomab [Bexxar] is effective in B-cell lymphoma that has progressed after rituximab therapy

Inpharma, Vol. 1, Iss. 1482, 2005-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Prostanoid-induced contractions are blocked by sulfonylureas

By Delaey C. Van de Voorde J.

European Journal of Pharmacology, Vol. 280, Iss. 2, 1995-07 ,pp. : 179-184

Elsevier

Access to resources Recommend Favorite

Ximelagatran [Exanta; AstraZeneca] has experienced a setback in the EU mutual recognition procedure

Inpharma, Vol. 1, Iss. 1438, 2004-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Myocardial Protection from Either Ischaemic Preconditioning or Nicorandil Is Not Blocked by Gliclazide

By Maddock Helen Siedlecka Sylvia Yellon Derek

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 2, 2004-03 ,pp. : 113-119

Springer Publishing Company

Access to resources Recommend Favorite